← United States · Coverage record
US · SEC FORM 4
RAPT Therapeutics, Inc.
RAPT · — · CIK 0001673772 · Healthcare
INSIDER SIGNAL
0 qualifying P purchase groups
in the current 180-day scoring window
0 Form 4 transaction lines observed in the same window
0 sales · 0 option, withholding, award, gift or other lines
WHY NO ACTIVE SIGNAL?
Score anatomy
No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.
Why is there no score?
- No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
- Sales and other Form 4 activity remain visible as context and do not create a negative score.
Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.
Insider activity timeline
No Form 4 transaction event is present in the current 180-day window.
Purchase breadth, concentration & cluster buying
These modules activate when qualifying purchases enter the 180-day research window.
SIGNAL HISTORY
Scores are archived only when the company qualifies for a published US buy-signal snapshot. Last qualifying purchase: 2023-03-14 · Robbins Wendye.
Recent Form 4 activity
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
Market context
Market context has not been captured for this ticker yet. The daily market-context job processes the US universe in rotating batches.
Short interest
The FINRA report lists no short interest for this ticker.
FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.
Historical equity purchases
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2023-03-14 | Robbins Wendye | Purchase (P) | Common Stock | 5,000 | USD 19.52 | USD 97,612 | SEC filing ↗ |
| 2022-05-25 | COLUMN GROUP II, LP; Column Group IV GP, LP; Column Group IV, LP; Column Group IV-A, LP; TCG IV GP, LLC | Purchase (P) | Common Stock | 1,900 | USD 12.45 | USD 23,655 | SEC filing ↗ |
| 2022-05-25 | COLUMN GROUP II, LP; Column Group II GP, LP; Column Group LLC; GOEDDEL DAVID V; Kutzkey Tim; PONOI CAPITAL, LP; Ponoi Capital II, LP; Ponoi II Management, LLC; Ponoi Management, LLC; Svennilson Peter | Purchase (P) | Common Stock | 1,900 | USD 12.45 | USD 23,655 | SEC filing ↗ |
| 2022-05-24 | COLUMN GROUP II, LP; Column Group IV GP, LP; Column Group IV, LP; Column Group IV-A, LP; TCG IV GP, LLC | Purchase (P) | Common Stock | 16,314 | USD 12.00 | USD 195,768 | SEC filing ↗ |
| 2022-05-24 | COLUMN GROUP II, LP; Column Group II GP, LP; Column Group LLC; GOEDDEL DAVID V; Kutzkey Tim; PONOI CAPITAL, LP; Ponoi Capital II, LP; Ponoi II Management, LLC; Ponoi Management, LLC; Svennilson Peter | Purchase (P) | Common Stock | 16,314 | USD 12.00 | USD 195,768 | SEC filing ↗ |
| 2022-05-23 | COLUMN GROUP II, LP; Column Group IV GP, LP; Column Group IV, LP; Column Group IV-A, LP; TCG IV GP, LLC | Purchase (P) | Common Stock | 10,236 | USD 12.50 | USD 127,950 | SEC filing ↗ |
| 2022-05-23 | COLUMN GROUP II, LP; Column Group II GP, LP; Column Group LLC; GOEDDEL DAVID V; Kutzkey Tim; PONOI CAPITAL, LP; Ponoi Capital II, LP; Ponoi II Management, LLC; Ponoi Management, LLC; Svennilson Peter | Purchase (P) | Common Stock | 10,236 | USD 12.50 | USD 127,950 | SEC filing ↗ |
| 2022-05-10 | Young Rodney KB | Purchase (P) | Common Stock | 5,000 | USD 10.53 | USD 52,650 | SEC filing ↗ |
| 2022-05-10 | Robbins Wendye | Purchase (P) | Common Stock | 7,000 | USD 11.04 | USD 77,282 | SEC filing ↗ |
| 2022-05-10 | COLUMN GROUP II, LP; Column Group IV GP, LP; Column Group IV, LP; Column Group IV-A, LP; TCG IV GP, LLC | Purchase (P) | Common Stock | 1,250,000 | USD 10.67 | USD 13,337,500 | SEC filing ↗ |
| 2022-05-10 | COLUMN GROUP II, LP; Column Group II GP, LP; Column Group LLC; GOEDDEL DAVID V; Kutzkey Tim; PONOI CAPITAL, LP; Ponoi Capital II, LP; Ponoi II Management, LLC; Ponoi Management, LLC; Svennilson Peter | Purchase (P) | Common Stock | 1,250,000 | USD 10.67 | USD 13,337,500 | SEC filing ↗ |
| 2021-10-18 | Robbins Wendye | Purchase (P) | Common Stock | 500 | USD 30.70 | USD 15,350 | SEC filing ↗ |
| 2021-10-13 | Robbins Wendye | Purchase (P) | Common Stock | 400 | USD 29.69 | USD 11,876 | SEC filing ↗ |
| 2021-08-24 | Robbins Wendye | Purchase (P) | Common Stock | 525 | USD 30.99 | USD 16,270 | SEC filing ↗ |
| 2021-08-23 | Robbins Wendye | Purchase (P) | Common Stock | 1,475 | USD 31.38 | USD 46,292 | SEC filing ↗ |
Form 4 evidence
15 transaction lines in the latest 365-day window; 307 in local history.
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-03-03 | Young Rodney KB | U (U) | Common Stock | 3,304 | USD — | USD — | SEC filing ↗ |
| 2026-03-03 | Wong Brian Russell | U (U) | Common Stock | 64,102 | USD — | USD — | SEC filing ↗ |
| 2026-03-03 | Lyons-Williams Lori | U (U) | Common Stock | 4,956 | USD — | USD — | SEC filing ↗ |
Show recent Form 4 evidence (15 grouped rows)
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-03-03 | Young Rodney KB | U (U) | Common Stock | 3,304 | USD — | USD — | SEC filing ↗ |
| 2026-03-03 | Wong Brian Russell | U (U) | Common Stock | 64,102 | USD — | USD — | SEC filing ↗ |
| 2026-03-03 | Lyons-Williams Lori | U (U) | Common Stock | 4,956 | USD — | USD — | SEC filing ↗ |
| 2026-03-03 | Kozick Linda | U (U) | Common Stock | 4,956 | USD — | USD — | SEC filing ↗ |
| 2026-03-03 | Giordano Michael F | U (U) | Common Stock | 4,956 | USD — | USD — | SEC filing ↗ |
| 2026-03-03 | GRAY MARY ANN | U (U) | Common Stock | 4,956 | USD — | USD — | SEC filing ↗ |
| 2026-03-03 | Dombkowski Ashley L. | U (U) | Common Stock | 4,956 | USD — | USD — | SEC filing ↗ |
| 2026-03-03 | Brockstedt Dirk G. | U (U) | Common Stock | 4,648 | USD — | USD — | SEC filing ↗ |
| 2026-03-03 | Braunstein Scott | U (U) | Common Stock | 4,956 | USD — | USD — | SEC filing ↗ |
| 2026-01-30 | Lyons-Williams Lori | Award / grant (A) | Common Stock | 4,956 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-01-30 | Kozick Linda | Award / grant (A) | Common Stock | 4,956 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-01-30 | Giordano Michael F | Award / grant (A) | Common Stock | 4,956 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-01-30 | GRAY MARY ANN | Award / grant (A) | Common Stock | 4,956 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-01-30 | Dombkowski Ashley L. | Award / grant (A) | Common Stock | 4,956 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-01-30 | Braunstein Scott | Award / grant (A) | Common Stock | 4,956 | USD 0.00 | USD 0 | SEC filing ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
Snapshot & identity
| Snapshot date | 2026-10-18 |
|---|---|
| Ranking version | US-v1.2 |
| Data quality | PASS ELIGIBLE · — |
| Ticker | RAPT |
| CIK | 0001673772 |
| Sector | Healthcare |
| Industry | — Yahoo Finance |
| SEC SIC | 2834 Pharmaceutical Preparations |
| Exchange | — |
Data coverage
| Local Form 4 history | 307 transaction lines from 2020-01-30 to 2026-03-03 70 P purchase lines · 144 S sale lines · 93 other lines |
|---|---|
| SEC company submissions | Open SEC filings ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.